...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Institutional investor >A Shot in the Arm for Health Care Deals
【24h】

A Shot in the Arm for Health Care Deals

机译：保健交易一臂之力

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Consumers maybe holding on to their wallets, but health care companies are on a buying spree. Global M&A volume for the sector -including Pfizer's $68 billion acquisition of Wyeth - rose to $128 billion in the first quarter of 2009, compared with just $18 billion in the previous quarter and $30.5 billion in the same period a year earlier. Considering that first-quarter M&A activity was down 36 percent from rnyear-ago levels, according to Dealogic, the upsurge by drug companies is welcome news for bankers, who had their busiest spate of deal making since the fourth quarter of 1999, when health care companies made $157 billion worth of transactions. But bankers are working harder for their money these days. The 1999 benchmark was achieved with 282 deals, while the sector's volume in the latest quarter was based on 442 deals. In today's recessionary environment, however, few complaints are likely to be voiced.
机译：消费者可能会坚持自己的钱包，但是医疗保健公司却在疯狂购买。包括辉瑞公司以680亿美元收购惠氏公司在内，该行业的全球并购交易量在2009年第一季度增至1280亿美元，而上一季度仅为180亿美元，去年同期为305亿美元。根据Dealogic的数据，考虑到第一季度的并购活动比去年同期下降了36％，制药公司的高涨对银行家来说是可喜的消息。自1999年第四季度以来，银行家的交易最为繁忙，当时医疗保健行业公司进行了价值1,570亿美元的交易。但是如今，银行家们正在努力争取钱。 1999年的基准交易达到282笔交易，而该行业最近一季度的交易量基于442笔交易。但是，在当今的衰退环境中，很少有人会抱怨。

著录项

  • 来源
    《Institutional investor》 |2009年第3期|19-19|共1页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号